Published in Aliment Pharmacol Ther on July 15, 2005
Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia. J Gastroenterol (2013) 1.97
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX. Surg Endosc (2009) 1.31
Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract (2007) 1.24
Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. BMC Gastroenterol (2011) 1.11
Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci (2008) 1.04
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol (2014) 1.01
Novel approaches to inhibition of gastric acid secretion. Curr Gastroenterol Rep (2010) 0.96
Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc (2014) 0.95
Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci (2010) 0.93
New and future drug development for gastroesophageal reflux disease. J Neurogastroenterol Motil (2013) 0.93
The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled? J Neurogastroenterol Motil (2010) 0.92
Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol (2011) 0.91
Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc (2012) 0.91
Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf) (2014) 0.91
Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. Br J Clin Pharmacol (2010) 0.87
More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy. J Gastroenterol (2014) 0.86
Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol (2009) 0.86
Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy. Clin Transl Gastroenterol (2012) 0.86
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterol (2014) 0.85
Medical management of patients after bariatric surgery: Principles and guidelines. World J Gastrointest Surg (2014) 0.84
Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms. J Clin Biochem Nutr (2011) 0.84
The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor. Int J Clin Pract (2008) 0.84
Unmet Needs in the Treatment of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2015) 0.82
The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole. Aliment Pharmacol Ther (2013) 0.82
Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study. BMC Gastroenterol (2013) 0.82
Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol (2014) 0.82
Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci (2009) 0.81
Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract (2013) 0.80
Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. World J Gastroenterol (2011) 0.80
Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease. World J Gastroenterol (2013) 0.79
Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics (Sao Paulo) (2011) 0.79
Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients. BMC Gastroenterol (2014) 0.79
The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease. J Clin Biochem Nutr (2012) 0.78
The Value of U/S to Determine Priority for Upper Gastrointestinal Endoscopy in Emergency Room. Medicine (Baltimore) (2015) 0.78
Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application? Gut (2006) 0.78
Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life. Med Sci Monit (2015) 0.78
Esophageal pH testing in patients refractory to proton pump inhibitor therapy. Can J Gastroenterol (2008) 0.78
Dose-response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes. Eur J Clin Pharmacol (2011) 0.78
The value of branded proton pump inhibitors: formulary considerations. P T (2011) 0.78
Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia. Therap Adv Gastroenterol (2008) 0.78
Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studies. Int J Clin Pract (2012) 0.77
Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations. BMC Gastroenterol (2014) 0.77
Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results. Surg Endosc (2015) 0.77
Comparing the Areas of Interest in the Field of Functional Gastrointestinal Disorder and Neurogastroenterology and Motility Between the East and the West. J Neurogastroenterol Motil (2015) 0.76
The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. Gastroenterol Res Pract (2014) 0.76
Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. World J Gastroenterol (2015) 0.76
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease. Clin Exp Gastroenterol (2010) 0.76
Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms. Medicine (Baltimore) (2016) 0.76
25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut Liver (2016) 0.76
The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis. Sci Rep (2016) 0.75
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole. Clin Exp Gastroenterol (2016) 0.75
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol (2015) 0.75
Management of Asymptomatic Erosive Esophagitis: An E-Mail Survey of Physician's Opinions. Gut Liver (2013) 0.75
Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy. World J Gastroenterol (2017) 0.75
Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy. J Clin Biochem Nutr (2017) 0.75
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease. Therap Adv Gastroenterol (2017) 0.75
Antireflux Surgery in Korea: A Nationwide Study from 2011 to 2014. Gut Liver (2016) 0.75
Understanding gastro-oesophageal reflux disease: a patient-cluster analysis. Int J Clin Pract (2008) 0.75
A Quantitative Structure-Activity Relationship and Molecular Modeling Study on a Series of Heteroaryl- and Heterocyclyl-Substituted Imidazo[1,2-a]Pyridine Derivatives Acting as Acid Pump Antagonists. Biochem Res Int (2013) 0.75
Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors. World J Gastrointest Pharmacol Ther (2016) 0.75
A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life. Curr Ther Res Clin Exp (2016) 0.75
GERD assessment including pH metry predicts a high response rate to PPI standard therapy. BMC Gastroenterol (2013) 0.75
Proton pump inhibitor failure in gastro-oesophageal reflux disease--what about eosinophilic oesophagitis? Aliment Pharmacol Ther (2006) 0.75
Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial. Curr Ther Res Clin Exp (2017) 0.75
Construction, internal validation and implementation in a mobile application of a scoring system to predict nonadherence to proton pump inhibitors. PeerJ (2017) 0.75
Comparing resource utilization and gastrointestinal outcomes in patients treated with either standard-dose or high-dose proton pump inhibitors: a matched cohort study. Dig Dis Sci (2008) 0.75
Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease. Dig Dis Sci (2017) 0.75
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Viral clearance without destruction of infected cells during acute HBV infection. Science (1999) 6.78
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82
The hippocampus, memory, and place cells: is it spatial memory or a memory space? Neuron (1999) 4.36
Control of fatty acid metabolism. I. Induction of the enzymes of fatty acid oxidation in Escherichia coli. J Bacteriol (1969) 4.12
Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut (2003) 3.69
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res (2000) 3.09
Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology (1998) 2.76
Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis (1987) 2.68
Epidural steroids for treating "failed back surgery syndrome": is fluoroscopy really necessary? Anesth Analg (1999) 2.48
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Abolition of long-term stability of new hippocampal place cell maps by NMDA receptor blockade. Science (1998) 2.25
Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci U S A (1990) 2.04
The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene (1991) 1.98
Triple approach in the diagnosis of dominant breast masses: combined physical examination, mammography, and fine-needle aspiration. J Surg Oncol (1994) 1.79
Use of the ED as a regular source of care: associated factors beyond lack of health insurance. Ann Emerg Med (1997) 1.75
3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced Bolus-Chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol (2008) 1.74
A multiscale random field model for Bayesian image segmentation. IEEE Trans Image Process (1994) 1.66
Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J Infect Dis (1995) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Pneumothorax. A complication of fine needle aspiration of breast tumors. Acta Cytol (1994) 1.53
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol (2001) 1.52
Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis (1993) 1.52
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A (1997) 1.48
Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med (1982) 1.44
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J (1989) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A (1994) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi]. Eur J Pharmacol (1995) 1.34
Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS (1998) 1.33
cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets. J Virol (1992) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Randomised study of myringotomy, amoxycillin/clavulanate, or both for acute otitis media in infants. Lancet (1989) 1.29
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trial. Aliment Pharmacol Ther (2005) 1.29
Use of antimicrobial drugs in general hospitals: patterns of prophylaxis. N Engl J Med (1979) 1.28
Osteomyelitis of the pelvis. J Bone Joint Surg Br (1993) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem (1995) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Penetrating esophageal injuries: multicenter study of the American Association for the Surgery of Trauma. J Trauma (2001) 1.19
Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis. J Antimicrob Chemother (1990) 1.19
The changing clinical spectrum of liver abscess: the Jerusalem experience. Postgrad Med J (1994) 1.15
Aberrant rearrangement of the kappa light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature (1983) 1.14
Cluster of neonatal infections in Jerusalem due to unusual biochemical variant of Enterobacter sakazakii. Eur J Clin Microbiol Infect Dis (2002) 1.14
The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology (2000) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet (1980) 1.13
Infection of a chimpanzee with hepatitis C virus grown in cell culture. J Gen Virol (1998) 1.13
Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation (1998) 1.13
Radioimmunoassay and characterization of woodchuck hepatitis virus core antigen and antibody. Virus Res (1985) 1.13
Replication and serial passage of infectious Heliothis nucleopolyhedrosis virus in an established line of Heliothis zea cells. J Invertebr Pathol (1971) 1.12
Problems in the control of hypertension in the community. Can Med Assoc J (1978) 1.11
ACTH and MSH production by a single cloned mouse pituitary tumor cell line. Endocrinology (1973) 1.11
Social behaviour and susceptibility to infection in house mice (Mus musculus): effects of group size, aggressive behaviour and status-related hormonal responses prior to infection on resistance to Babesia microti. Parasitology (1994) 1.10
Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States. J Acquir Immune Defic Syndr (2001) 1.10
Human class I supertypes and CTL repertoires extend to chimpanzees. J Immunol (1998) 1.10
Asymptomatic giardiasis in children. Pediatr Infect Dis J (1989) 1.09
Use of antibiotic exposure to detect postoperative infections. Infect Control Hosp Epidemiol (1998) 1.09
Outcome and utility of scoring systems in the management of the mangled extremity. Am J Surg (1996) 1.08
Serial blood gas studies during cardiopulmonary resuscitation. Ann Intern Med (1970) 1.08
Brain aging: changes in the nature of information coding by the hippocampus. J Neurosci (1997) 1.07
Progressive liver calcifications in neonatal coxsackievirus infection. Pediatr Radiol (2000) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Arterial oxygen tension in acute myocardial infarction. Serial analysis of clinical state and blood gas changes. Am Heart J (1970) 1.06
Differences between ectopic MSH and pituitary MSH. J Clin Endocrinol Metab (1971) 1.06
Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis (1998) 1.06
Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment Pharmacol Ther (2002) 1.05
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology (1999) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines. J Med Chem (1999) 1.04
Mnemonic correlates of unit activity in the hippocampus. Brain Res (1986) 1.03
Brain aging: impaired coding of novel environmental cues. J Neurosci (1997) 1.03
Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine (1997) 1.01
Social behaviour, stress and susceptibility to infection in house mice (Mus musculus): effects of duration of grouping and aggressive behaviour prior to infection on susceptibility to Babesia microti. Parasitology (1993) 1.00
Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology (1999) 1.00
Perception of missing fundamental by a species of songbird (Sturnus vulgaris). J Comp Psychol (1986) 1.00
Ciliary body neurilemoma recurring after 15 years. Graefes Arch Clin Exp Ophthalmol (1988) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Complex trauma of war captivity: a prospective study of attachment and post-traumatic stress disorder. Psychol Med (2008) 0.98
Studies on the mechanism of fatty acid synthesis. XXII. Salt activation of the fatty acid-synthesizing enzymes of Escherichia coli. J Biol Chem (1969) 0.98
Autoimmune thyroid disease and antiphospholipid antibodies. Am J Hematol (2000) 0.98
Laser control of molecular processes. Annu Rev Phys Chem (1992) 0.98
Secondary traumatization among wives of PTSD and post-concussion casualties: distress, caregiver burden and psychological separation. Brain Inj (2000) 0.97
Environmental enrichment, immunocompetence, and resistance to Babesia microti in male mice. Physiol Behav (1996) 0.97
Work of breathing through different sized endotracheal tubes. Crit Care Med (1986) 0.97
Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metab (1973) 0.96
Preliminary characterization of the pituitary melanocyte stimulating hormones of several vertebrate species. Endocrinology (1972) 0.95
Predictors of occult scleral rupture. Ophthalmology (1994) 0.95
In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide-stimulated peripheral blood lymphocytes. J Infect Dis (1989) 0.95
Attempts to transmit hepatitis B virus to chimpanzees by arthropods. S Afr Med J (1991) 0.95
Serum expression of a VK structure, VK-11, associated with inulin antibodies controlled by gene(s) linked to the mouse IgCH complex. J Immunol (1979) 0.94
Extracorporeal life support for adult cardiorespiratory failure. Surgery (1993) 0.94
Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr (1992) 0.94
Infections caused by Pseudomonas pickettii in association with permanent indwelling intravenous devices: four cases and a review. Clin Infect Dis (1993) 0.93
Varicella in Chimpanzees. J Med Virol (1996) 0.93
A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees. J Infect Dis (1996) 0.93
Utilization of chimeras between human (HM-175) and simian (AGM-27) strains of hepatitis A virus to study the molecular basis of virulence. J Virol (1998) 0.92